Aplastic anemia and monosomy 7-associated dysmegakaryocytopoiesis

American Journal of Clinical Pathology

Volumn 126, Issue 6, 2006, Pages 925-930

  Dolan, Michelle M ^a   Singleton, Timothy P ^a   Neglia, Joseph ^a   Cioc, Adina ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aplastic anemia; Monosomy 7; Myelodysplasia

Indexed keywords

CD61 ANTIGEN;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL COUNT; CELL SIZE; CELL STRUCTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE INTERVAL; DYSMEGAKARYOCYTOPOIESIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 33845428649     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/50GWDKVWU3VWL5XW     Document Type: Article

References (30)

1. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336:1365-1372.
2. Maciejewski J, Selleri C. Evolution of clonal cytogenetic abnormalities in aplasric anemia. Leuk Lymphoma. 2004;45:433-440.
3. Maciejewski JP, Risitano A, Sloand EM, et al. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood. 2002;99:3129-3135.
4. Kojima S, Ohara A, Tsuchida M, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002;100:786-790.
5. Kaito K, Kobayashi M, Katayama T, et al. Long-term administration of G-CSF for aplastic anemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297-303.
6. Satoh A, Miwa H, Daimaru O, et al. Aplastic anaemia associated with a Philadelphia chromosome and monosomy 7 during immunosuppressive therapy. Eur J Haematol. 2003;71:130-132.
7. Hashino S, Imamura M, Tanaka J, et al. Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7. Ann Hematol. 1996;72:337-339.
8. Ohsaka A, Sugahara Y, Imai Y, et al. Evolution of severe aplastic anemia to myelodysplasia with monosomy 7 following granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy. Intern Med. 1995;34:892-895.
9. Nishimura M, Yamada T, Andoh T, et al. Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy. Int J Hematol. 1998;68:203-211.
10. Barrios NJ, Kirkpatrick DV, Levin ML, et al. Transient expression of trisomy 21 and monosomy 7 following cyclosporine A in a patient with aplastic anemia. Leuk Res. 1991;15:531-533.
11. Sashida G, Tauchi T, Katagiri T, et al. Transformation of severe aplastic anemia into myelodysplastic syndrome with monosomy 7: monoclonal origin detected by HUMARA gene analysis during the aplastic anemia phase [letter]. Haematologica. 2000;85:665-666.
12. Shibuya A, Ishii S, Obinata K. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors. Hematology. 2002;7:301-304.
13. de Planque MM, Kluin-Nelemans HC, van Krieken HJM, et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol. 1988;70:55-62.
14. Ohara A, Kojima S, Hamajima N, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009-1013.
15. Applebaum FR, Barrall J, Storb R, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol. 1987;15:1134-1139.
16. Mikhailova N, Sessarego M, Fugazza G, et al. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica. 1996;81:418-422.
17. Socie G, Rosenfeld S, Frickhofen N, et al. Late clonal diseases of treated aplastic anemia. Semin Hematol. 2000;37:91-101.
18. Shimamura A, Guinan EC. Acquired aplastic anemia. In: Nathan DG, Orkin SH, Ginsburg D, et al, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Philadelphia, PA: Saunders; 2003:256-279.
19. Peterson LC, Brunning RD. Bone marrow specimen processing. In: Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1391-1405.
20. Raghavachar A, Janssen JWG, Schrezenmeier H, et al. Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia. Blood. 1995;86:2938-2947.
21. Keung Y-K, Pettenati MJ, Cruz JM, et al. Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol. 2001;66:167-171.
22. Ohga S, Ohara A, Hibi S. Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis. Br J Haematol. 2002;118:313-319.
23. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or disease linked by a common pathophysiology? Semin Hematol. 2000;37:15-29.
24. Yoshida Y. The aplasia-myelodysplasia enigma: a re-emerging question. Int J Hematol. 1999;70:65-67.
25. Ohshima K, Kikuchi M, Takeshita M. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. J Pathol. 1995;177:181-189.
26. Fohlmeister I, Fischer R, Modder B, et al. Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol. 1985;38:1218-1224.
27. Orazi A, Albitar M, Heerema NA, et al. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol. 1997;107:268-274.
28. Zipursky A, Wang H, Brown EJ, et al. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome. Blood. 1994;84:2278-2282.
29. Tripputi P, Cassani B, Alfano R, et al. Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leuk Res. 2001;25:735-739.
30. Gerritsen WR, Donohue J, Bauman J, et al. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood. 1992;80:2217-2224.